绝经与多发性硬化女性功能结局及疾病生物标志物的关联
该前瞻性纵向观察队列纳入184名绝经后多发性硬化女性,随访中位13年,以分段线性混合模型分析发现绝经是MSFC恶化(斜率差0.08,95%CI 0.01-0.14,p=0.0163)和sNfL升高(斜率差-0.95,95%CI -1.74至-0.16,p=0.0194)的拐点,而EDSS呈相反方向(斜率差0.05,95%CI 0.01-0.09,p=0.0200)。
要点
- 绝经与MSFC恶化和sNfL升高的斜率变化相关,提示神经元损伤积累加速。
- EDSS在绝经后斜率变化方向与MSFC和sNfL相反。
- 非线性模型显示sNfL和EDSS拐点位于末次月经后3年内,MSFC未显示。
核心结论
- 绝经过渡可能代表多发性硬化中神经元损伤积累和功能下降的拐点。
研究设计与样本
- 前瞻性纵向观察队列,纳入184名符合纳入标准的绝经后多发性硬化女性。
- 主要功能结局为基于表现的多次 sclerosis 功能复合(MSFC),主要生物标志物结局为血清神经丝轻链(sNfL)。
- 采用分段线性混合模型回归分析,调整年龄、BMI和吸烟,以绝经时为先验拐点。
主要发现
- 随访中位13年(四分位距4,范围1-17),中位MS病程24年(四分位距13,范围3-64),中位EDSS评分2.5(四分位距2,范围0-8)。
- 自然绝经中位年龄50岁(四分位距5,范围33-60),17%的参与者使用过任何全身性绝经激素治疗。
- 绝经反映MSFC恶化的拐点(斜率差0.08,95%CI 0.01-0.14,p=0.0163)和sNfL升高的拐点(斜率差-0.95,95%CI -1.74至-0.16,p=0.0194)。
- EDSS的斜率变化方向相反(斜率差0.05,95%CI 0.01-0.09,p=0.0200)。
- 调整多个协变量后结果仍显著;非线性回归模型显示sNfL和EDSS的拐点位于末次月经后3年内,MSFC未显示。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The impact of menopause on the brain is not well understood. Hormonal changes, including puberty and pregnancy, influence the onset and course of multiple sclerosis (MS). After menopause, a worsening of MS disease trajectory measured on the clinician-rated Expanded Disability Status Scale (EDSS) was reported in some, but not all, studies. Evaluating the association between menopause and more objective measures of CNS injury is warranted. This study sought to assess the trajectory of objective functional outcomes and disease biomarkers in women with MS before and after menopause in a longitudinal prospective observational cohort. METHODS: Data were collected prospectively from a longitudinally followed MS cohort, including the performance-based Multiple Sclerosis Functional Composite (MSFC) as the primary functional outcome and the paraclinical marker of neuronal injury serum neurofilament light chain (sNfL) as the primary biomarker outcome. Outcomes were analyzed using segmented linear mixed model regressions adjusted for age, BMI, and tobacco use, with a change in slope at the time of menopause, as the a priori inflection point. RESULTS: One hundred and eighty-four postmenopausal women met inclusion criteria. Participants were followed for a median of 13 years (interquartile range [IQR] = 4, range: 1-17). The median MS duration was 24 years (IQR = 13, range: 3-64), and the median EDSS score was 2.5 (IQR = 2, range: 0-8). The median age at natural menopause was 50 years (IQR = 5, range: 33-60); 17% of participants used any systemic menopausal hormone therapy. Menopause reflected an inflection point in MSFC worsening (slope difference 0.08, 95% CI 0.01, 0.14, p = 0.0163) and increase in serum neurofilament light chain (slope difference -0.95, 95% CI -1.74 to -0.16, p = 0.0194) while the opposite was found for EDSS (slope difference 0.05, 95% CI 0.01-0.09, p = 0.0200). Findings remained significant after adjustment for multiple covariates. When using additional nonlinear regression modeling, similar inflection points were found (within 3 years of the final menstrual period) for sNfL and EDSS but not MSFC. DISCUSSION: The menopausal transition may represent an inflection in accumulation of neuronal injury and functional decline in MS.
引用
- Silverman HE, Bostrom A, Nylander AN, et al. Association of Menopause With Functional Outcomes and Disease Biomarkers in Women With Multiple Sclerosis. Neurology. 2024. PMID: 39715474. doi:10.1212/WNL.0000000000210228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。